Clinical Trial Update: Ursodiol in Treating Patients With Barrett Esophagus and Low-Grade Dysplasia [Phase 2]

View source ↗

Summary

Phase 2 trial update on Ursodiol for Barrett esophagus with low-grade dysplasia completed; results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Barrett Esophagus
• Esophageal Carcinoma

Drugs mentioned

• URSODIOL (ursodiol)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Barrett Esophagus, Esophageal Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2015-05-15